Page 8 - Daniel Altmann News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The approval of the Oxford-AstraZeneca vaccine has been hailed as a “game-changer” and a “triumphant moment” in the battle against coronavirus. One of the key people behind the new jab said it will provide some respite in the “blizzard” of the pandemic, and hope for the future. Professor Andrew Pollard, director of the Oxford Vaccine Group and chief investigator of the Oxford Vaccine Trial, said the development and approval of the vaccine is “an absolute triumph of academic collaboration”. He told BBC’s Radio Radio 4 Today programme: “This really is a great moment in what�...

Posted on December 30th, 2020 Courtesy The Times (UK) Astrazeneca chief promises 2 million doses a week The Covid vaccine developed by Oxford University and the drugmaker Astrazeneca has been approved for use in Britain, with government advisers saying that a single shot could achieve 70 per cent protection. The jab was authorised by the Medicines and Healthcare Products Regulatory Agency (MHRA) this morning amid mounting concerns over the new fast-spreading coronavirus strain and rising hospital admissions. The first injections are due on Monday. The Oxford vaccine r...

The approval of the Oxford-AstraZeneca vaccine has been hailed as a “game-changer” and a “triumphant moment” in the battle against coronavirus. One of the key people behind the new jab said it will provide some respite in the “blizzard” of the pandemic, and hope for the future. Professor Andrew Pollard, director of the Oxford Vaccine Group and chief investigator of the Oxford Vaccine Trial, said the development and approval of the vaccine is “an absolute triumph of academic collaboration”. He told BBC’s Radio Radio 4 Today programme: “This really is a great moment in what�...

The approval of the Oxford-AstraZeneca vaccine has been hailed as a “game-changer” in the battle against coronavirus. One of the biggest benefits of this vaccine is that it does not need to be stored at very cold temperatures, like the Pfizer jab - which would make "an enormous difference" according to one expert. Andrew Hayward, professor of infectious diseases epidemiology at University College London, and a member of the Government’s New and Emerging Respiratory Virus Threats Advisory Group (Nervtag), said: "It means that all of the centres that would normally get involved in v...

The approval of the Oxford-AstraZeneca vaccine has been hailed as a “game-changer” and a “triumphant moment” in the battle against coronavirus. One of the key people behind the new jab said it will provide some respite in the “blizzard” of the pandemic, and hope for the future. Professor Andrew Pollard, director of the Oxford Vaccine Group and chief investigator of the Oxford Vaccine Trial, said the development and approval of the vaccine is “an absolute triumph of academic collaboration”. He told BBC’s Radio Radio 4 Today programme: “This really is a great moment in what�...